IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
about
The H19 non-coding RNA is essential for human tumor growthCleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosisStat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activationInteraction of TAFII105 with selected p65/RelA dimers is associated with activation of subset of NF-kappa B genesRegulation of Fas (CD95)-induced apoptosis by nuclear factor-KB and tumor necrosis factor- alpha in macrophagesInvolvement of 5'-flanking kB-like sites within bcl-x gene in silica-induced bcl-x expressionImmediate early gene X-1 interacts with proteins that modulate apoptosisImpaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic miceIEX-1: a new ERK substrate involved in both ERK survival activity and ERK activationNF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosisThe prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosisTRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-kappaBThe human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factorsTherapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancerNF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytesGenetic control of the innate immune responseRole of T cell-nuclear factor κB in transplantationA1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factorTRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosisUpregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cellsHost-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytesNur77 as a survival factor in tumor necrosis factor signalingMullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivoElevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 geneExpression profiling of major histocompatibility and natural killer complex genes reveals candidates for controlling risk of graft versus host diseaseRole of EspF in host cell death induced by enteropathogenic Escherichia coli.Serial analysis of gene expression in renal carcinoma cells reveals VHL-dependent sensitivity to TNFalpha cytotoxicity.Microarray analysis of Shigella flexneri-infected epithelial cells identifies host factors important for apoptosis inhibitionImmediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells.Inhibition of the 53BP2S-mediated apoptosis by nuclear factor kappaB and Bcl-2 family proteins.Effects of nuclear factor-kappaB on rat hepatocyte regeneration and apoptosis after 70% portal branch ligation.Mitoquinone restores platelet production in irradiation-induced thrombocytopenia.Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.Function for NF-kB in neuronal survival: regulation by atypical protein kinase C.Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts.The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-kappaB signaling and cell survivalCD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-kappaB/Rel transcription factors on chemotherapy-induced apoptosis.
P2860
Q21144433-DA9E1A52-D3D9-4EDD-8AB5-C375427DA7BBQ22010649-55278BEE-8AB3-4069-A227-8ACCD81E7FFAQ22254226-8510F2D4-C114-4C3A-8775-BCD1C7AF77C1Q22254261-1ABE766F-C9D6-4CEB-8D96-71A474EA244EQ23910429-1E43362A-14CC-43D6-BFD4-4CA4BBE4B16FQ23912832-7BFF3E0B-8D08-4C68-B971-34588EA21C39Q24305468-84DFD4FF-A073-4172-AC5B-008513E3BAF2Q24530757-A55689DC-5999-4398-9BDA-B7CD579E29E1Q24534869-526E6E98-765E-4F4B-972E-839EC9D9FE7EQ24554454-C71597A7-45EC-442D-B849-11794D04271FQ24608044-F2999DD1-214C-42E2-84DD-5B1CA757D812Q24649790-2EB88E8E-DF30-40C2-9EB0-CDC6553F51EBQ24670601-E519BE77-DD82-4926-A4A8-2A7DB138A0A8Q24681630-EF967029-3744-474B-B6BF-6014E91FCC28Q24685661-BD9BB7FC-1905-47F5-AD34-0F831239F3EAQ24800607-57FAD71A-CD36-46D4-9DA5-39D552BD1461Q26852416-87B55B01-3D44-440C-A039-813E59CC83CCQ28137979-46E5D706-D94B-4E27-BEBA-8F61B53AF1BFQ28138885-863EBD5D-8814-44C1-B9B8-5155674EDC58Q28384366-432FA134-ADA2-4C4D-B9BE-D0A8729D84DAQ28386446-B86EFA38-0F22-47EB-87C4-AFCADF9310D7Q28508741-E14F14B8-97C3-495E-B304-68B32E92D8A1Q28511631-A77FB30F-A707-45FD-942C-FE2988DFF2C1Q28577022-5A76E8A2-EA0A-4AFA-8AE4-AA9EBBFA655BQ28589777-CFA6A4CF-EE37-4EE0-A373-C1C179F9089AQ28743195-04F1C74A-D734-4691-BFD1-417327DF0AD6Q30168292-5EAB7140-29DB-4403-9C20-4793514D0E9CQ30724798-E88F63D7-C407-4663-AE5E-C0E3FD2F6F1EQ30982152-0AE130CF-E17E-4F44-91FC-0B4F24321832Q31163900-44D2A914-1C2F-4D1F-A5A8-20F9AF5015F9Q33221677-212396D8-903B-4461-9AC1-6B711890EE5BQ33232133-959E92F6-AC41-4B0C-9E48-1B3F5D99513EQ33416435-21DBEF0E-9CCD-4785-8E47-4296DE92BD04Q33663188-361BE03E-A46C-4E10-A99C-A9DEDFF2C6A7Q33671991-1224FC62-688F-4759-AFD3-FB1036D4F6FBQ33707301-145FB9CE-16BE-470E-854E-30D0881869FEQ33773434-41CC74EF-1696-4FF8-A8DE-0193081E0139Q33797150-5481FC8A-2F1B-479D-982F-07E06403CFDEQ33825084-D184CE04-D14E-47AF-8AE4-9A01E816C7B0Q33837951-06AF3C48-4E24-4211-9EFF-093849CC837B
P2860
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@ast
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@en
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@en-gb
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@nl
type
label
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@ast
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@en
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@en-gb
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@nl
prefLabel
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@ast
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@en
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@en-gb
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@nl
P2093
P3181
P1433
P1476
IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival
@en
P2093
P304
P3181
P356
10.1126/SCIENCE.281.5379.998
P407
P577
1998-08-14T00:00:00Z